000			01938 a2200565 4500
005			20250517213832.0
264		0	_c20190627
008			201906s 0 0 eng d
022			_a1470-8736
024	7		_a10.1042/CS20180040 _2doi
040			_aNLM _beng _cNLM
100	1		_aCroyal, Mikaël
245	0	0	_aPCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. _h[electronic resource]
260			_bClinical science (London, England : 1979) _c05 2018
300			_a1075-1083 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAnticholesteremic Agents _xpharmacology
650	0	4	_aApoprotein(a) _xbiosynthesis
650	0	4	_aCholesterol _xblood
650	0	4	_aCross-Over Studies
650	0	4	_aFemale
650	0	4	_aLipids _xblood
650	0	4	_aLipoprotein(a) _xblood
650	0	4	_aMacaca fascicularis
650	0	4	_aMale
650	0	4	_aPCSK9 Inhibitors
700	1		_aTran, Thi-Thu-Trang
700	1		_aBlanchard, Rose Hélène
700	1		_aLe Bail, Jean-Christophe
700	1		_aVillard, Elise F
700	1		_aPoirier, Bruno
700	1		_aAguesse, Audrey
700	1		_aBillon-Crossouard, Stéphanie
700	1		_aRamin-Mangata, Stéphane
700	1		_aBlanchard, Valentin
700	1		_aNativel, Brice
700	1		_aChemello, Kévin
700	1		_aKhantalin, Ilya
700	1		_aThedrez, Aurélie
700	1		_aJaniak, Philip
700	1		_aKrempf, Michel
700	1		_aBoixel, Christophe
700	1		_aLambert, Gilles
700	1		_aGuillot, Etienne
773	0		_tClinical science (London, England : 1979) _gvol. 132 _gno. 10 _gp. 1075-1083
856	4	0	_uhttps://doi.org/10.1042/CS20180040 _zAvailable from publisher's website
999			_c28355428 _d28355428